Search

everythinglearnresearchcommunity

for

Search:↓

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Cepharanthine may help hair growth by increasing IGF-I in scalp cells.

Widened sweat ducts are a very specific sign of scarring hair loss.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Women with PCOS have more emotional and body image issues than healthy women.

A woman died from cancer that spread from a long-standing cyst on her abdomen.

LALPS causes non-scarring hair loss along the Blaschko line, with unique trichoscopic findings.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Certain gut bacteria may protect against alopecia areata, while others may increase the risk.

Patients often experience long-lasting changes to their hair after stem cell transplants.

Mnemonics with one letter are useful and easy to remember for learning dermatology.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Dermatoscopy and videodermatoscopy are useful for diagnosing and monitoring various skin, hair, and nail conditions.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Skin problems are very common in people with end-stage kidney disease.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.